LENSAR (NASDAQ:LNSR) Posts Earnings Results, Misses Expectations By $1.40 EPS

LENSAR (NASDAQ:LNSR - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($1.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($1.40), Zacks reports. The business had revenue of $16.73 million for the quarter, compared to the consensus estimate of $14.95 million. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%. LENSAR updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

LENSAR Stock Up 3.7 %

Shares of NASDAQ LNSR traded up $0.48 during mid-day trading on Monday, reaching $13.48. 269,727 shares of the company were exchanged, compared to its average volume of 99,623. The stock has a market capitalization of $156.57 million, a PE ratio of -9.23 and a beta of 0.66. LENSAR has a 52 week low of $2.67 and a 52 week high of $14.20. The company's 50 day moving average price is $9.58 and its 200 day moving average price is $7.10.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital upped their price objective on shares of LENSAR from $12.00 to $16.00 and gave the stock a "buy" rating in a research report on Friday.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.